Specific Inhibition of p300-HAT Alters Global Gene Expression and Represses HIV Replication

Chemistry and Biology

Volumn 14, Issue 6, 2007, Pages 645-657

  Mantelingu, K ^a   Reddy, B A Ashok ^a   Swaminathan, V ^a   Kishore, A Hari ^a   Siddappa, Nagadenahalli B ^a   Kumar, G V Pavan ^a   Nagashankar, G ^a   Natesh, Nagashayana ^b   Roy, Siddhartha ^c   Sadhale, Parag P ^c   Ranga, Udaykumar ^a   Narayana, Chandrabhas ^a   Kundu, Tapas K ^a  

^a JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^b Central Government Health Scheme Dispensary No 3   (India)

^c INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

CHEMBIOL; DNA

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CELL CYCLE PROTEIN; ENZYME INHIBITOR; GARCINOL; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; P300-CBP-ASSOCIATED FACTOR; PROTEIN P53; TERPENE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL; ARTICLE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CHROMATIN; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; SYNTHESIS; T LYMPHOCYTE; UPREGULATION; VIROLOGY; VIRUS REPLICATION;

ACETYLATION; ANIMALS; ANTI-HIV AGENTS; CELL CYCLE PROTEINS; CELL SURVIVAL; CHROMATIN; DOWN-REGULATION; ENZYME INHIBITORS; GENE EXPRESSION; HELA CELLS; HISTONE ACETYLTRANSFERASES; HISTONES; HIV-1; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; T-LYMPHOCYTES; TERPENES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34250308083     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2007.04.011     Document Type: Article

References (44)

1. Batta K., Das C., Gadad S., Shandilya J., and Kundu T.K. Reversible acetylation of nonhistone proteins: role in cellular function and disease. Subcell. Biochem. 41 (2007) 193-214
2. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu. Rev. Biochem. 70 (2001) 81-120
3. Sterner D.E., and Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64 (2000) 435-459
4. Iyer N.G., Ozdag H., and Caldas C. p300/CBP and cancer. Oncogene 23 (2004) 4225-4231
5. Goodman R.H., and Smolik S. CBP/p300 in cell growth, transformation and development. Genes Dev. 14 (2000) 1553-1577
6. Kundu T.K., Palthan V.B., Wang Z., An W., Cole P.A., and Roeder R.G. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol. Cell 6 (2000) 551-561
7. Chan H.M., Krstic-Demonacos M., Smith L., Demonacos C., and La Thangue N.B. Acetylation control of the retinoblastoma tumour-suppressor protein. Nat. Cell Biol. 3 (2001) 667-674
8. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 384 (1996) 641-643
9. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 (1996) 953-959
10. Das C., and Kundu T.K. Transcriptional regulation by the acetylation of nonhistone proteins in humans-a new target for therapeutics. IUBMB Life 57 (2005) 137-149
11. Giordano A., and Avantaggiati M.L. p300 and CBP: partners for life and death. J. Cell. Physiol. 181 (1999) 218-230
12. Quivy V., and Van Lint C. Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system. Biochem. Pharmacol. 64 (2002) 925-934
13. Barrero M.J., and Malik S. Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation. Mol. Cell 24 (2006) 233-243
14. Varier R.A., and Kundu T.K. Chromatin modifications (acetylation/deacetylation/methylation) as new targets for HIV therapy. Curr. Pharm. Des. 12 (2006) 1975-1993
15. Cereseto A., Manganaro L., Gutierrez M.I., Terreni M., Fittipaldi A., Lusic M., Marcello A., and Giacca M. Acetylation of HIV-1 integrase by p300 regulates viral integration. EMBO J. 24 (2005) 3070-3081
16. Knights C.D., Catania J., Di Giovanni S., Muratoglu S., Perez R., Swartzbeck A., Quong A.A., Zhang X., Beerman T., Pestell R.G., et al. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J. Cell Biol. 173 (2006) 533-544
17. Sakaguchi K., Herrera J.E., Saito S., Miki T., Bustin M., Vassilev A., Anderson C.W., and Appella E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12 (1998) 2831-2841
18. Guidez F., Howell L., Isalan M., Cebrat M., Alani R.M., Ivins S., Hormaeche I., McConnell M.J., Pierce S., Cole P.A., et al. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 25 (2005) 5552-5566
19. Qiu Y., Zhao Y., Becker M., John S., Parekh B.S., Huang S., Hendarwanto A., Martinez E.D., Chen Y., Lu H., et al. HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol. Cell 22 (2006) 669-679
20. McKinsey T.A., and Olson E.N. Cardiac histone acetylation-therapeutic opportunities abound. Trends Genet. 20 (2004) 206-213
21. Barnes P.J., Adcock I.M., and Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur. Respir. J. 25 (2005) 552-563
22. Lau O.D., Kundu T.K., Soccio R.E., Ait-Si-Ali S., Khalil E.M., Vassilev A., Wolffe A.P., Nakatani Y., Roeder R.G., and Cole P.A. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol. Cell 5 (2000) 589-595
23. Biel M., Kretsovali A., Karatzali E., Papamathekis J., and Giannis A. Design, synthesis and biological evaluation of a small-molecule inhibitor of the histone acetyltransferase Gcn5. Angew. Chem. Int. Ed. Engl. 43 (2004) 3974-3976
24. Stimson L., Rowlands M.G., Newbatt Y.M., Smith N.F., Raynaud F.I., Rogers P., Bavetsias V., Gorsuch S., Jarman M., Bannister A., et al. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Mol. Cancer Ther. 4 (2005) 1521-1532
25. Balasubramanyam K., Swaminathan V., Ranganathan A., and Kundu T.K. Small molecule modulators of histone acetyltransferase p300. J. Biol. Chem. 278 (2003) 19134-19140
26. Balasubramanyam K., Altaf M., Varier R.A., Swaminathan V., Ravindran A., Sadhale P.P., and Kundu T.K. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 279 (2004) 33716-33726
27. Pavan Kumar G.V., Ashok Reddy B.A., Arif M., Kundu T.K., and Narayana C. Surface-enhanced Raman scattering studies of human transcriptional coactivator p300. J. Phys. Chem. B 110 (2006) 16787-16792
28. Zhao Y., Lu S., Wu L., Chai G., Wang H., Chen Y., Sun J., Yu Y., Zhou W., Zheng Q., et al. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol. Cell. Biol. 26 (2006) 2782-2790
29. Liu G., and Lozano G. p21 stability: linking chaperones to a cell cycle checkpoint. Cancer Cell 7 (2005) 113-114
30. Xu Y., and Mellgren R.L. Calpain inhibition decreases the growth rate of mammalian cell colonies. J. Biol. Chem. 277 (2002) 21474-21479
31. Yu L., Lenardo M.J., and Baehrecke E.H. Autophagy and caspases: a new cell death program. Cell Cycle 3 (2004) 1124-1126
32. Nakanishi K., Sudo T., and Morishima N. Endoplasmic reticulum stress signaling transmitted by ATF6 mediates apoptosis during muscle development. J. Cell Biol. 169 (2005) 555-560
33. Lee C.W., Lin W.N., Lin C.C., Luo S.F., Wang J.S., Pouyssegur J., and Yang C.M. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300 and histone acetylation. J. Cell. Physiol. 207 (2006) 174-186
34. Simonsson M., Kanduri M., Gronroos E., Heldin C.H., and Ericsson J. The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J. Biol. Chem. 281 (2006) 39870-39880
35. Al-Kuraya K., Novotny H., Bavi P.P., Siraj A.K., Uddin S., Ezzat A., Al Sanea N., Al-Dayel F., Al-Mana H., Sheikh S.S., et al. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. J. Clin. Pathol. (2006) 10.1136/jcp.2006.038281 in press. Published online August 1, 2006
36. Sudol M., Kuo C.F., Shigemitsu L., and Alvarez-Buylla A. Expression of the yes proto-oncogene in cerebellar Purkinje cells. Mol. Cell. Biol. 9 (1989) 4545-4549
37. Adjei A.A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst. 93 (2001) 1062-1074
38. Waeber G., Delplanque J., Bonny C., Mooser V., Steinmann M., Widmann C., Maillard A., Miklossy J., Dina C., and Hani E.H. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat. Genet. 24 (2001) 291-295
39. Johnson P.R., Burgess J.K., Underwood P.A., Au W., Pomiris M.H., Tamm M., Ge Q., Roth M., and Black J.L. Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J. Allergy Clin. Immunol. 113 (2004) 690-696
40. Mohiddin S.A., Ahmed Z.M., Griffith A.J., Tripodi D., Friedman T.B., Fananapazir L., and Morell R.J. Novel association of hypertrophic cardiomyopathy, sensorineural deafness and a mutation in unconventional myosin VI (MYO6). J. Med. Genet. 41 (2004) 309-314
41. Arellano-Llamas A., Garcia F.J., Perez D., Cantu D., Espinosa M., De la Garza G., Maldonado V., and Melendez-Zajgla J. High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. BMC Cancer 6 (2006) 256
42. Eshed Y., Feinberg K., Poliak S., Sabanay H., Sarig-Nadir O., Bermingham J.R., and Peles E. Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron 47 (2005) 215-229
43. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 4 (2006) 263-273
44. Das C., Hizume K., Batta K., Kumar B.R., Gadad S.S., Ganguly S., Lorain S., Verreault A., Sadhale P.P., Takeyasu K., et al. Transcriptional coactivator PC4, a chromatin-associated protein induces chromatin condensation. Mol. Cell Biol. 26 (2006) 8303-8315